Cynata Therapeutics signs stem cell agreement with Waisman Biomanufacturing – Proactive Investors Australia
|
Cynata Therapeutics signs stem cell agreement with Waisman Biomanufacturing
Proactive Investors Australia Cynata Therapeutics (ASX:CYP) has signed a manufacturing agreement with Waisman Biomanufacturing under which Waisman will undertake process development, scale-up and clinical-grade production of Cynata’s proprietary Cymerus™ off-the-shelf stem … |
